Cargando…

Reviewing the Ethical Concerns of the Convalescent Plasma Therapy in COVID-19

The understanding of coronavirus disease 2019 (COVID-19) is evolving periodically. There is also a marked increase in COVID-19 patients’ demand for the provision of COVID-19 convalescent plasma (CCP) therapy. With the review of the literature, the stage of speculation is quickly moving towards confo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Raturi, Manish, Kala, Mansi, Das, Kunal, Kusum, Anuradha
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Thieme Medical and Scientific Publishers Pvt. Ltd. 2021
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8154358/ https://www.ncbi.nlm.nih.gov/pubmed/34054244 http://dx.doi.org/10.1055/s-0041-1727585

Ejemplares similares

Locally harvested Covid-19 convalescent plasma could probably help combat the geographically determined SARS-CoV-2 viral variants
por: Raturi, Manish, et al.
Publicado: (2021)

A Cross-Sectional Comparative Characterization of Hematological Changes in Patients with COVID-19 Infection, Non-COVID Influenza-like Illnesses and Healthy Controls
por: Kala, Mansi, et al.
Publicado: (2022)

Current Perspectives of convalescent plasma therapy in COVID-19
por: Sahu, Kamal Kant, et al.
Publicado: (2020)

Covid-19 convalescent plasma therapy: Analyzing the factors that led to its failure in India
por: Bansal, Naveen, et al.
Publicado: (2021)

COVID-19convalescent plasma use in the oncology and geriatric patients: Ethical aspects in transfusion medicine
por: Bansal, N., et al.
Publicado: (2022)

The active role of a blood center in outpacing the transfusion transmission of COVID-19
por: Raturi, Manish, et al.
Publicado: (2020)

A novel scoring system for selecting the target patients of COVID-19 convalescent plasma therapy: A hypothesis
por: Bansal, Naveen, et al.
Publicado: (2022)

Pure Red Cell Aplasia Encountered in a Tertiary Care Hematology Laboratory: A Series of Nine Distinctive Cases
por: Kala, Mansi, et al.
Publicado: (2022)

COVID-19 vaccination: The impact on the selection criteria of the convalescent plasma donors
por: Bansal, N., et al.
Publicado: (2021)

Convalescent Covid-19 plasma: Back-to-basics and ethics, and next steps
por: Garraud, O., et al.
Publicado: (2021)

Convalescent plasma therapy in patients with COVID-19
por: Altuntas, Fevzi, et al.
Publicado: (2021)

Convalescent plasma therapy in patients with COVID-19
por: Altuntas, Fevzi, et al.
Publicado: (2021)

COVID-19 convalescent plasma therapy and immunodeficiency
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2021)

Challenges of Convalescent Plasma Therapy on COVID-19
por: Zhao, Qian, et al.
Publicado: (2020)

Convalescent plasma therapy in COVID 19: Every dark cloud has a silver lining
por: Deokar, Kunal, et al.
Publicado: (2020)

Variant of Concern-Matched COVID-19 Convalescent Plasma Usage in Seronegative Hospitalized Patients
por: Franchini, Massimo, et al.
Publicado: (2022)

COVID-19 convalescent plasma
por: Tobian, Aaron A. R., et al.
Publicado: (2022)

Convalescent plasma (CP) therapy in patients with COVID-19
por: Cakir, Banu
Publicado: (2021)

The Three Pillars of COVID-19 Convalescent Plasma Therapy
por: Franchini, Massimo, et al.
Publicado: (2021)

Convalescent Plasma Therapy for COVID-19: State of the Art
por: Focosi, Daniele, et al.
Publicado: (2020)

Convalescent plasma as a potential therapy for COVID-19
por: Chen, Long, et al.
Publicado: (2020)

The blood supply management amid the COVID-19 outbreak
por: Raturi, M., et al.
Publicado: (2020)

Medication of Hydroxychloroquine, Remdesivir and Convalescent Plasma during the COVID-19 Pandemic in Germany—An Ethical Analysis
por: Voit, Katja, et al.
Publicado: (2021)

Convalescent plasma: Alternative or promising therapy?
por: Mina, Fahmida Begum, et al.
Publicado: (2021)

Endorsing a permanent lifting of the ban on men who have sex with men and transgender from donating their whole blood
por: Raturi, Manish, et al.
Publicado: (2022)

Bioethical perspective of convalescent plasma therapy for COVID-19: A systematic review
por: Munir, M.A., et al.
Publicado: (2021)

Convalescent plasma therapy in COVID-19 and discharge status: A systematic review
por: Agarwal, Neeraj, et al.
Publicado: (2021)

Suggested guidelines for convalescent plasma therapy for the treatment of COVID-19
por: De Santis, Gil Cunha, et al.
Publicado: (2021)

Effect of time and titer in convalescent plasma therapy for COVID-19
por: de Candia, Paola, et al.
Publicado: (2021)

Perplexing issues for convalescent immune plasma therapy in COVID-19
por: Ozdemir, Oner
Publicado: (2021)

Efficacy of convalescent plasma therapy in severe COVID-19 patients
por: Akay Cizmecioglu, Hilal, et al.
Publicado: (2021)

Effectiveness of convalescent plasma therapy in severe COVID-19 patients
por: Duan, Kai, et al.
Publicado: (2020)

COVID-19 Convalescent Plasma and Concomitant Therapies in PassITON
por: Casadevall, Arturo, et al.
Publicado: (2022)

Convalescent plasma for COVID-19 considerations
por: Adiwinata Pawitan, Jeanne
Publicado: (2021)

Convalescent plasma to treat COVID-19
por: Bloch, Evan M.
Publicado: (2020)

Convalescent plasma for patients with COVID-19
por: Zeng, Furong, et al.
Publicado: (2020)

Serosurveys and convalescent plasma in COVID-19
por: Pérez-Cameo, Cristina, et al.
Publicado: (2020)

COVID-19 convalescent plasma transfusion
por: Langhi, Dante Mário, et al.
Publicado: (2020)

Convalescent plasma in outpatients with COVID-19
por: Focosi, Daniele, et al.
Publicado: (2022)

The resurgence of convalescent plasma therapy
por: The Lancet Haematology
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_p3qkhu2aha7f55he8diq0ps35t